- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-26-0185652

About Astrella Pharmaceutical Private Limited
Data last updated:
Astrella Pharmaceutical Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 27 November 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U51909PN2018PTC180384. Its GSTIN is 27AARCA6058L1Z0 (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Sachin Rajmal Mahor and Sachin Rameshrao Chavan.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at S. No. 66 Santosh Nagar Katraj Dhankawadi, Pune, Maharashtra, India – 411046.
As per the financials filed for FY 2024, the company reported a revenue of ₹3.41 Cr, a growth of 60% compared to the previous year. For the same year it recorded a net profit of ₹7.73 Lakh (net margin 2.3%) and EBITDA of ₹10.5 Lakh (EBITDA margin 3.1%). Revenue has grown at a compounded annual rate (CAGR) of 85% over three years.
Astrella Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-26-0185652). For more details, the company can be reached via its website astrellapharma.com.
Company details
Recognitions & Rankings of Astrella Pharmaceutical
Contact details
Astrella Pharmaceutical Private Limited's registered office is in Pune, Maharashtra. Its website is astrellapharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressS. No. 66 Santosh Nagar Katraj Dhankawadi, Pune, Maharashtra, India – 411046
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Astrella Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Astrella Pharmaceutical is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers retail trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 47 | Retail trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Astrella Pharmaceutical Private Limited, buy the company report.
Financials of Astrella Pharmaceutical Private Limited
FY 2023 filings availableAstrella Pharmaceutical Private Limited reported revenue of ₹3.41 Cr (up 60% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 85% over three years, including 60% growth in the latest year. EBITDA rose 6% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹10.5 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹7.73 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.1% | ||||
| Net Profit Margin | 2.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Astrella Pharmaceutical Private Limited, buy the company report.
Board of directors of Astrella Pharmaceutical Private Limited
Astrella Pharmaceutical has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sachin Rajmal Mahor | Director | 27 Nov 2018 | 7 Years 11 Months | Current |
| Sachin Rameshrao Chavan | Director | 27 Nov 2018 | 7 Years 11 Months | Current |
| Harshavardhan Pravinkumar Doshi | Director | 27 Nov 2018 | 7 Years 11 Months | Current |
Auditor
Astrella Pharmaceutical Private Limited is audited by AASHISH LONDHE & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AASHISH LONDHE & ASSOCIATES | FY 2023 | 137968W |
Shareholding
The shareholding of Astrella Pharmaceutical Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Astrella Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Astrella Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Astrella Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Astrella Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AARCA6058L1Z0 | Maharashtra | Active | 22 Jan 2019 |
To see the full GST registrations and return filing status of Astrella Pharmaceutical Private Limited, buy the company report.
Recent activity
Astrella Pharmaceutical Private Limited has 3 board changes on record since 2018: 3 appointments. The latest: Harshavardhan Pravinkumar Doshi was appointed as Director on 27 Nov 2018.
Frequently asked questions
Astrella Pharmaceutical is an active private limited company based in Pune, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 27 November 2018 (8+ years old) and is registered under CIN U51909PN2018PTC180384.
Astrella Pharmaceutical has 3 current directors:
- Sachin Rajmal Mahor - Director
- Sachin Rameshrao Chavan - Director
- Harshavardhan Pravinkumar Doshi - Director
The latest financial statements of Astrella Pharmaceutical on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Astrella Pharmaceutical is 27AARCA6058L1Z0, registered in Maharashtra.
The CIN (Corporate Identification Number) of Astrella Pharmaceutical is U51909PN2018PTC180384. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Astrella Pharmaceutical was incorporated on 27 November 2018, making it 8+ years old. It is registered with the Registrar of Companies, Pune.
Harshavardhan Pravinkumar Doshi was appointed as Director on 27 Nov 2018. Sachin Rajmal Mahor was appointed as Director on 27 Nov 2018. Sachin Rameshrao Chavan was appointed as Director on 27 Nov 2018.
Yes, Astrella Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-26-0185652).
Astrella Pharmaceutical can be reached through the website astrellapharma.com. Its registered office is in Pune, Maharashtra, India.
The registered office of Astrella Pharmaceutical is at S. No. 66 Santosh Nagar Katraj Dhankawadi, Pune, Maharashtra, India – 411046.

